Lakeshore Biopharma Co. Ltd.Preferred / convertible
13F holders, Q1 2024 (March 31)25holders
2famous investors
$0.08avg. 13F price*
At the end of Q1 2024, 25 institutions reported holding Lakeshore Biopharma Co. Ltd. in their 13F filings. The largest holders were Athos Capital Ltd ($93K), LMR Partners LLP ($75K) and Valliance Asset Management Ltd ($54K). 2 famous investors held it, including David E. Shaw ( of D. E. Shaw & Co.'s portfolio) and Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Lakeshore Biopharma Co. Ltd.
- Filed as
- YS BIOPHARMA CO LTD (Q1 2024)
- CUSIP
- G9845F117
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $1K |
| Exits | 4 | $3K |
Ownership 25 holders
| Athos Capital Ltd | — | No change | 128,981 | $93K |
| LMR Partners LLP | — | No change | 1,052,461 | $75K |
| Valliance Asset Management Ltd | — | No change | 750,000 | $54K |
| Jane Street Group, LLC | — | No change | 498,301 | $36K |
| BFAM Partners (Cayman) Ltd | — | No change | 550,000 | $28K |
| Finepoint Capital LP | — | No change | 489,999 | $25K |
| Cowen and Company, LLC | — | Add +17.6% | 235,533 | $17K |
| Bracebridge Capital, LLC | — | No change | 232,323 | $17K |
| Q Global Advisors, LLC | — | No change | 130,600 | $9K |
| Whitebox Advisors LLC | — | No change | 125,000 | $9K |
| Calamos Advisors LLC | — | No change | 146,040 | $7K |
| Walleye Capital LLC | — | No change | 99,905 | $7K |
| Saba Capital Management, L.P. | — | No change | 97,299 | $7K |
| Cantor Fitzgerald, L. P. | — | No change | 76,931 | $6K |
| Shaolin Capital Management LLC | — | No change | 76,200 | $5K |
| D. E. Shaw & Co. | — | No change | 100,000 | $5K |
| Exos Asset Management LLC | — | — | 50,000 | $4K |
| Clear Street LLC | — | Reduce -0.5% | 47,286 | $3K |
| Meteora Capital, LLC | — | No change | 25,000 | $2K |
| Citadel Advisors | — | New | 21,918 | $1K |
| SkyView Investment Advisors, LLC | — | No change | 12,210 | $1K |
| Ancora Advisors LLC | — | No change | 5,050 | $362 |
| HGC Investment Management Inc. | — | No change | 5,000 | $358 |
| Tower Research Capital LLC (TRC) | — | No change | 126 | $9 |
| UBS Group AG | — | New | 68 | $5 |
"% of holder's portfolio" is LAKESHORE BIOPHARMA CO LTD's weight in each manager's 13F, not the share of Lakeshore Biopharma Co. Ltd. the manager owns.